1. 117 A PHASE 3 STUDY OF LENALIDOMIDE VERSUS PLACEBO IN RBC TRANSFUSION-DEPENDENT (TD) PATIENTS WITH LOWER-RISK MDS WITHOUT DEL(5Q) UNRESPONSIVE OR REFRACTORY TO ERYTHROPOIESIS-STIMULATING AGENTS (ESAS). Issue 1 (April 2015) Authors: Santini, V.; Almeida, A.; Giagounidis, A.; Gröpper, S.; Jonasova, A.; Vey, N.; Mufti, G.J.; Buckstein, R.; Mittelman, M.; Platzbecker, U.; Shpilberg, O.; Ram, R.; del Canizo, C.; Gattermann, N.; Ozawa, K.; Risueno, A.; MacBeth, K.J.; Zhong, J.; Séguy, F.; Hoenekopp, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 119 UPDATE ON THE MULTICENTER MDS BIOREGISTRY PROJECT OF THE "KREBSHILFE-VERBUNDFORSCHUNGSPROJEKT MDS" OF THE GERMAN MDS STUDY GROUP. Issue 1 (April 2015) Authors: Schemenau, I.; Strupp, C.; Wulfert, M.; Schroeder, T.; Xicoy, B.; Nusch, A.; Langer, W.; Kalhori, N.; Haase, D.; Brümmendorf, T.; Schütte, J.; Ganser, A.; Parmentier, S.; Schulte, K.; Plewe, D.; Losem, C.; Biekmann, E.; Hoffmann, W.; Hahn, L.; Neise, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 160 ANALYSIS OF POSSIBLE BIOMARKERS TO PREDICT RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE. Issue 1 (April 2015) Authors: Kuendgen, A.; Müller-Thomas, C.; Lauseker, M.; Urbaniak, P.; Haferlach, T.; Alpermann, T.; Meggendorfer, M.; Schnittger, S.; Brings, C.; Wulfert, M.; Hildebrandt, B.; Betz, B.; Royer-Pokora, B.; Haas, R.; Gattermann, N.; Germing, U.; Götze, K. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry. Issue 1 (December 2016) Authors: Kaifie, A.; Kirschner, M.; Wolf, D.; Maintz, C.; Hänel, M.; Gattermann, N.; Gökkurt, E.; Platzbecker, U.; Hollburg, W.; Göthert, J.; Parmentier, S.; Lang, F.; Hansen, R.; Isfort, S.; Schmitt, K.; Jost, E.; Serve, H.; Ehninger, G.; Berdel, W.; Brümmendorf, T. Journal: Journal of hematology & oncology Issue: Volume 9:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dichotomous Synexpression of Fanconi Anemia/BRCA1 Pathway Proteins in Myelodysplastic Syndromes. (April 2017) Authors: Majidi, F.; Neukirchen, J.; Germing, U.; Cadeddu, R.P.; Braunstein, S.; Haas, R.; Gattermann, N. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of Lenalidomide Exposure on Response and Outcomes in Patients with Lower-Risk Non-Del(5Q) Myelodysplastic Syndromes (MDS). (April 2017) Authors: Garcia-Manero, G.; Santini, V.; Almeida, A.; Fenaux, P.; Gattermann, N.; Ozawa, K.; Goldberg, S.L.; Weaver, J.; Sugrue, M.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Increased Serum Ferritin and Genetic Instability in Myelodysplastic Syndromes. (April 2017) Authors: Ganster, C.; Westhofen, G.; Beier, F.; Rassaf, T.; Al-Ali, H.K.; Stuhlmann, R.; Glass, B.; Martin, R.; Bacher, U.; Brümmendorf, T.H.; Germing, U.; Gattermann, N.; Haase, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML. (February 2018) Authors: Schuler, E.; Frank, F.; Hildebrandt, B.; Betz, B.; Strupp, C.; Rudelius, M.; Aul, C.; Schroeder, T.; Gattermann, N.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 65(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA. (23rd June 2022) Authors: Stegelmann, F.; Jahn, E.; Koschmieder, S.; Heidel, F.; Hochhaus, A.; Hebart, H.; Isfort, S.; Reiter, A.; Bangerter, M.; Waller, C. F.; Wolleschak, D.; Scheid, C.; Göthert, J.; Schafhausen, P.; Kindler, T.; Radsak, M. P.; Gattermann, N.; Möhle, R.; von Bubnoff, N.; Schrade, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY. (23rd June 2022) Authors: Schulz, F.; Kostova, J.; Hildebrandt, B.; Nachtkamp, K.; Strupp, C.; Gattermann, N.; Lübbert, M.; Blum, S.; Parmentier, S.; Götze, K.; Lipke, J.; Beier, F.; Hofmann, W.-K.; Germing, U. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗